Else Nutrition is an award winning, category-leading food company that has developed a revolutionary preferred-alternative to dairy based infant's foods. An independent US-based study indicates significant feeding related disorders and symptoms in large majority of children.
An ever-alergetic generation: A Growing Concern
The US CDC reports that there is a growing prevalence of food sensitivity and allergies among children. These are not limited to GI issues but can bring with them related conditions that include asthma and other allergies. There is a need for a clear alternative to dairy based food products to address these concerns.
Gastrointestinal disorders in dairy based formula fed infants are quite common. A multi-centre study found that up to 78% of patients suffered with GI issues. These conditions are a major source of stress for both parents and children, and result in more frequent visits to health care providers. Addressing the root cause of these issues will improve the quality of life and health for the child.
The range of symptoms experienced by users of dairy and soy-based infant formulas can include colic, regurgitation, and bloating. The simple solution is to remove dairy and soy from the diet without sacrificing any of the benefits.
A Simple Solution for Significant Improvement
ELSE Nutrition offers a plant-based, non-soy, non-dairy, clean-ingredient formula.
"Improving lives and providing a real alternative to dairy for early childhood nutrition was the spark for starting Else and it is reassuring to see validation from moms that Else products are truly helping to make their families' lives better," says Hamutal Yitzhak, CEO and Co-Founder of Else Nutrition.
Not only do these products simplify healthy eating, by decreasing vomiting, reflux and spit-ups, they improve the moments of feeding, enjoyment and care shared between parents and their child. These benefits extend beyond feeding and digestion into the overall quality of life. After switching to ELSE Toddler, or ELSE Kids, over 75% of parents surveyed indicated that there were marked improvements in their child's health and well-being.
The Results are In: A Plant-Based Healthy Alternative that Kids Enjoy
Many parents have found ELSE plant based products to be a wholesome, enjoyable solution to their food sensitivity and allergy concerns. ELSE products are free from potentially harmful ingredients and include whole plant, non-GMO, minimally processed ingredients.
Initial study findings indicate the following significant benefits:
Increased infant weight gain
Reduction of GI related symptoms
Improved bowel movements
Reduction in the frequency and severity of rashes
In addition to providing good nutrition and an appealing lifestyle choice, children enjoy the taste of ELSE products and 90% of survey respondents said they would recommend it to their friends. This success has led ELSE to a top spot in Amazon sales in America, and an invitation from Amazon, to expand into European markets in early 2022.
ELSE Expertise in Children's Nutrition
The ELSE collection of products is not only easy to eat, easy to digest and easy to live with, it is built on a foundation of industry expertise, both in childhood nutrition and paediatric health. The ELSE leadership team includes executives and medical practitioners from top infant food producers and medical research institutions. ELSE is committed and well-resourced to deliver delicious, high quality, and nutritious products for families throughout the world.
The author of the Article, does not own any securities of the companies set forth in this Article, either directly or indirectly. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. The Article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of the information presented here is his or her own responsibility. This Article is not a solicitation for investment. The author does not render general or specific investment advice and the information provided herein above should not be considered a recommendation to buy or sell any security. The author does not endorse or recommend the business, products, services or securities of any company mentioned. This document contains forward-looking information and forward-looking statements, within the meaning of applicable securities legislation, (collectively, "forward-looking statements"), which reflect possible expectations for future growth, future business plans and opportunities, expected activities, and other statements about future events, results or performance. Wherever possible, words such as "predicts", "projects", "targets", "plans", "expects", "does not expect", "budget", "scheduled", "estimates", "forecasts", "anticipate" or "does not anticipate", "believe", "intend" and similar expressions or statements that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved, or the negative or grammatical variation thereof or other variations thereof, or comparable terminology have been used to identify forward-looking statements. These forward-looking statements include, among other things, statements relating to: (a) revenue generating potential; (b) market opportunity; (c) business plans and strategies; (d) services intended to offer; (e) milestone projections and targets; (f) expectations regarding receipt of approval for regulatory applications; (g) intentions to expand into other jurisdictions including the timeline expectations relating to those expansion plans; and (h) expectations with regarding ability to deliver shareholder value. Forward-looking statements are not a guarantee of future performance and are based upon a number of estimates and assumptions in light of experience and perception of trends, current conditions and expected developments, as well as other factors, that may or may not be relevant, and reasonable in the circumstances, as of the date of this document. The author makes provides no representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this document. The author shall have no liability whatsoever, under contract, tort, trust or otherwise, to any person resulting from the use of the information provided in this document or for alleged omissions from the information in this document. Any images, photos, graphs, tables or other information contained in this document are intended only for illustration purposes and are not necessarily indicative of past, present or future performance of entities ad persons mentioned in this document.